Defibrillation News and Research

RSS

Italy's amateur soccer league selects Cardiac Science as certified AED supplier

Italian soccer leagues have been at the forefront of promoting automated external defibrillators (AEDs) at sporting events ever since 2012 when Piermario Morosini, a 25-year-old midfielder for Livorno, suffered sudden cardiac arrest (SCA) during a match and died.

19 Aug 2014

New evidence for painless AF treatment to be presented at FCVB 2014

The first evidence for a shockless treatment for atrial fibrillation (AF) will be presented today at Frontiers in CardioVascular Biology (FCVB) 2014 in Barcelona, Spain. T

4 Jul 2014

ARCA biopharma announces genetic screening of first patient in GENETIC-AF Phase 2B/3 clinical trial

ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for cardiovascular diseases, today announced that the first patient has been genetically screened in GENETIC-AF, its Phase 2B/3 adaptive design clinical trial.

From Medtronic 18 Apr 2014

Boston Scientific to launch of S-ICD System into parts of Asia

Boston Scientific Corporation (NYSE: BSX) has expanded the launch of its S-ICD System into parts of Asia. The first implant of the S-ICD System in Asia was performed in Hong Kong by Prof. Hung Fat Tse, Professor of Cardiovascular Medicine, The University of Hong Kong and Department of Medicine, Queen Mary Hospital in Pokfulam, Hong Kong, under the proctorship of Dr. Martin Stiles, Director of Electrophysiology, Waikato Hospital in Hamilton, New Zealand.

8 Apr 2014

Binghamton University receives HEARTSafe Campus accreditation from NCEMSF

Binghamton University was recently awarded a HEARTSafe Campus accreditation from the National Collegiate Emergency Medical Services Foundation, making Binghamton one of only five colleges and universities in the United States and Canada to achieve the accreditation.

1 Apr 2014

Discovery could lead to improved early detection, prevention strategies for sudden cardiac death

UC Irvine researchers have found a specific genetic flaw that is connected to sudden death due to heart arrhythmia - a leading cause of mortality for adults around the world.

18 Feb 2014

INTENSIA family of ICDs and CRT-D devices receive CE mark approval

Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, announced today that the INTENSIA family of implantable cardioverter defibrillators and cardiac resynchronization therapy devices received CE (Conformité Européenne) mark approval. This family of devices includes the single-chamber INTENSIA VR, the dual-chamber INTENSIA DR and the INTENSIA SonR® CRT-D devices, all of which feature a DF-4 high voltage connector.

6 Dec 2013

Study assesses CPR with mechanical chest compression in patients with out-of-hospital cardiac arrest

Sten Rubertsson, M.D., Ph.D., of Uppsala University, Sweden and colleagues assessed whether cardiopulmonary resuscitation in which chest compressions are delivered with a mechanical device would result in superior 4-hour survival in patients with out-of-hospital cardiac arrest compared to CPR with manual chest compression.

19 Nov 2013

Johns Hopkins undergraduate students win first and third prize in national Collegiate Inventors Competition

A Johns Hopkins undergraduate biomedical engineering student team that devised a two-part system to improve the way life-saving shocks are delivered to hearts has earned first prize in the undergraduate division of the national Collegiate Inventors Competition.

16 Nov 2013

ZOLL Medical announces establishment of ZOLL Foundation

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today the establishment of the ZOLL Foundation, an independent entity organized for scientific and educational purposes.

16 Nov 2013

Students invent system to shock irregular heart back into normal rhythm more safely and effectively

Johns Hopkins undergraduate students have invented a system to shock a dangerously irregular heart back into normal rhythm more safely and effectively.

16 Nov 2013

Johns Hopkins students take the top honor for developing PrestoPatch system

A Johns Hopkins undergraduate biomedical engineering student team that devised a two-part system to improve the way life-saving shocks are delivered to hearts earned first-prize in the undergraduate division of a national Collegiate Inventors Competition. In the graduate-level competition, Isaac Kinde, a Johns Hopkins medical student, received third-place honors for developing a test to detect ovarian and endometrial cancers as part of a team at the Johns Hopkins Kimmel Cancer Center.

14 Nov 2013

WUSTL's Igor Efimov studies new potential treatment for irregular heartbeat

Although an irregular heartbeat is a common malady in the United States, affecting an estimated 5 million people, the treatments for it are limited in scope and effectiveness.

29 Oct 2013

Research reveals that only 7% of patients survive from out-of-hospital cardiac arrest

Survival for out-of-hospital cardiac arrest is just 7%, according to research presented at ESC Congress 2013 by Professor Xavier Jouven and Dr Wulfran Bougouin from France.

2 Sep 2013

Experts to discuss on resuscitation efforts at Euroanaesthesia

One of the most difficult moments faced by anaesthetists and other healthcare staff is when to carry on attempts to resuscitate a person, and when those efforts should reasonably stop. This dilemma is the subject of a session at Euroanaesthesia, the annual congress of the European Society of Anaesthesiology.

3 Jun 2013

ECMO may show promise as rescue strategy for select cardiac arrest patients

Extracorporeal membrane oxygenation, a procedure traditionally used during cardiac surgeries and in the ICU that functions as an artificial replacement for a patient's heart and lungs, has also been used to resuscitate cardiac arrest victims in Japan, Taiwan, and South Korea.

17 May 2013

ARCA biopharma, Medtronic to study effectiveness of Gencaro for prevention of atrial fibrillation

ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has entered into an agreement with Medtronic, Inc., a leader in medical technologies to improve the treatment of chronic diseases, including cardiac rhythm disorders, to collaborate on ARCA's proposed clinical trial, known as GENETIC-AF, of its lead developmental drug Gencaro (bucindolol hydrochloride).

From Medtronic 23 Apr 2013

Computational simulations can help understand, treat cardiac rhythm disorders

Computational models of the human heart can be very useful in studying not just the basic mechanisms of heart function, but also to analyze the heart in a diseased state, and come up with methods for diagnosis and therapy.

11 Apr 2013

Abell Foundation to award $50,000 to 3 Johns Hopkins researchers for medical inventions

Johns Hopkins' John Wong, Ph.D., has won a BioMaryland LIFE Award, and Ronald Berger, M.D., Ph.D., and Hien Nguyen, M.D., were awarded funds from the Abell Foundation, the researchers learned last week. Each of the winners will receive $50,000 to help develop their discoveries for clinical use.

27 Feb 2013

Semi-automatic shocks make long delays in CPR

Paramedics should avoid using defibrillators in semi-automatic mode, say researchers who found this increases interruptions to cardiopulmonary resuscitation in the 30 seconds preceding shock delivery.

6 Feb 2013

Defibrillation News and Research

Italy's amateur soccer league selects Cardiac Science as certified AED supplier

New evidence for painless AF treatment to be presented at FCVB 2014

ARCA biopharma announces genetic screening of first patient in GENETIC-AF Phase 2B/3 clinical trial

Boston Scientific to launch of S-ICD System into parts of Asia

Binghamton University receives HEARTSafe Campus accreditation from NCEMSF

Discovery could lead to improved early detection, prevention strategies for sudden cardiac death

INTENSIA family of ICDs and CRT-D devices receive CE mark approval

Study assesses CPR with mechanical chest compression in patients with out-of-hospital cardiac arrest

Johns Hopkins undergraduate students win first and third prize in national Collegiate Inventors Competition

ZOLL Medical announces establishment of ZOLL Foundation

Students invent system to shock irregular heart back into normal rhythm more safely and effectively

Johns Hopkins students take the top honor for developing PrestoPatch system

WUSTL's Igor Efimov studies new potential treatment for irregular heartbeat

Research reveals that only 7% of patients survive from out-of-hospital cardiac arrest

Experts to discuss on resuscitation efforts at Euroanaesthesia

ECMO may show promise as rescue strategy for select cardiac arrest patients

ARCA biopharma, Medtronic to study effectiveness of Gencaro for prevention of atrial fibrillation

Computational simulations can help understand, treat cardiac rhythm disorders

Abell Foundation to award $50,000 to 3 Johns Hopkins researchers for medical inventions

Semi-automatic shocks make long delays in CPR

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News